ISO 13485:2016 Focus Audit Passed!
July 20, 2026
Pleased to share that Tuatara Dx has passed the ISO 13485:2016 focus audit that took place last week. Succesfully completing the audit confirms that we
Pleased to share that Tuatara Dx has passed the ISO 13485:2016 focus audit that took place last week. Succesfully completing the audit confirms that we
Brainport Eindhoven has published an article about Tuatara Dx and our new rapid DNA test for personalized medicine! Their well written article describes how we
Pleased to share that Tuatara Dx has passed the ISO 13485:2016 focus audit that took place last week. Succesfully completing the audit confirms that we
Brainport Eindhoven has published an article about Tuatara Dx and our new rapid DNA test for personalized medicine! Their well written article describes how we
Pleased to share that Tuatara Dx has passed the ISO 13485:2016 focus audit that took place last week. Succesfully completing the audit confirms that we
Brainport Eindhoven has published an article about Tuatara Dx and our new rapid DNA test for personalized medicine! Their well written article describes how we
Pleased to share that Tuatara Dx has passed the ISO 13485:2016 focus audit that took place last week. Succesfully completing the audit confirms that we
Brainport Eindhoven has published an article about Tuatara Dx and our new rapid DNA test for personalized medicine! Their well written article describes how we
We develop molecular diagnostic tests, including qPCR and isothermal amplification, tailored to specific project needs.
We work on new diagnostic technologies to improve performance, usability, and reliability.
We develop our own diagnostic products designed to support personalized patient care.